RBR-99qw5h招募中未知
Functional, clinical and systemic effects of the body electrical stimulation on bariatric surgery postoperative
niversidade Federal de São Carlos0 个研究点开始时间: 2016年8月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 20Y 至 45Y（—）
入选标准
- •This research will include obese (BMI 35 kg / m2) or morbidly obese (BMI 40 kg / m2) for at least three years or more without positive results to conventional treatments (pharmacological or not) aged 20 to 45 years will undergo surgery of Gastric Bypass (CBG). Patients with BMI> 30 kg / m2 may also be included according to medical team decision regarding the presence of important comorbidities indicated by Brazilian Bariatric Consensus.
排除标准
- •Exclusion criteria are volunteers with orthopedic or neurological impairments that unable participation in an exercise program; myocardial infarction (within the beginning of the six-month study period); implanted pacemaker or any metallic synthesis; unstable angina; chronic disorders of the heart rhythm; moderate or severe valvular heart disease; consistent story of heart disease; uncontrolled hypertension; uncontrolled diabetes mellitus and / or insulin-dependent; beta-blocker users; postmenopausal women and participation in a regular program of physical activity at baseline. It will be also excluded from the present study any COPD volunteers or patients presenting other respiratory diseases or who present any contraindication to cardiopulmonary exercise test or condition that may limit the performance of the functional tests; distal artery diseases; inflammatory diseases; kidney diseases; and liver diseases with documented diabetic neuropathy; cognitive impairment; difficulty in understanding and / or adherence to study procedures; reported using illicit drugs and pregnancy.
研究者
相似试验
尚未招募
4 期
Surgical treatment in painful hip and restricted hip movement patientsCTRI/2019/11/021942Government Medical college and Hospital Aurangabad
招募中
1 期
Study on the Therapeutic Effect and Mechanism of Bushen Yisui Capsules Against Multiple Sclerosis with Depression Based on Multi-modality Analysismultiple sclerosisITMCTR2000003158Beijing Tiantan Hospital, Capital Medical University
进行中（未招募）
1 期
A Study exploring the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Non-Small Cell Lung Cancer (NSCLC)EUCTR2018-000462-11-ESBristol-Myers Squibb International Corporation250
进行中（未招募）
1 期
A Study exploring the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Non-Small Cell Lung Cancer (NSCLC)Treatment-Naive Stage IV or recurrent Non-Small Cell Lung Cancer (NSCLC)MedDRA version: 21.1Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.1Level: LLTClassification code 10080083Term: Advanced lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-000462-11-BEBristol-Myers Squibb International Corporation250
进行中（未招募）
1 期
A Study exploring the Biologic Effects and Biomarkers of Nivolumab incombination with Ipilimumab in Subjects with Non-Small Cell Lung Cancer(NSCLC)Treatment-Naive Stage IV or recurrent Non-Small Cell Lung Cancer(NSCLC)MedDRA version: 20.0Level: LLTClassification code 10007096Term: Cancer of lungSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-000462-11-ITBRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATIO250